Picture of Conmed logo

CNMD Conmed Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for Conmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line55.540.928.69.5262.5
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items8.4714.224.126.531.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-16.9-44.3-23.6-29.9-55.7
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities65.674.795.164.5112
Capital Expenditures-12.8-16.5-20.1-13-14.9
Purchase of Fixed Assets
Other Investing Cash Flow Items-16.20-368-0.625
Acquisition of Business
Sale of Fixed Assets
Cash from Investing Activities-29.1-16.5-388-13.6-14.9
Financing Cash Flow Items-0.372-20.1-69.9-2.992.95
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-34.9-72.3301-52.1-102
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.19-15.18.351.5-6.51

Or unlock with your email

Or unlock with your email